Bacterial p-nitrophenol 4-monooxygenase and mammalian metabolizing enzymes

Bacterial p-nitrophenol 4-monooxygenase (PnpA) and mammalian metabolizing enzymes, such as Cytochrome P450 2E1 (CYP2E1), represent distinct biological systems that process the environmental pollutant p-nitrophenol (PNP). In bacteria like Pseudomonas sp. WBC-3, PnpA is a flavin-dependent monooxygenase that initiates the degradation of PNP into 4-nitrocatechol, allowing the organism to utilize the compound as a carbon and nitrogen source (PubMed: 19139101, UniProt: A4F6E4). In mammals, PNP is primarily encountered as a toxic metabolite derived from the breakdown of organophosphate pesticides like parathion (PubMed: 10910740). Mammalian enzymes, specifically CYP2E1, oxidize PNP to 4-nitrocatechol, while other phase II enzymes like sulfotransferases and UDP-glucuronosyltransferases facilitate its conjugation and subsequent renal excretion (PubMed: 1531577, UniProt: P05181). This entry is considered incorrect as a single therapeutic target because it conflates a specific bacterial bioremediation enzyme with a broad class of mammalian metabolic proteins. These enzymes are not currently utilized as targets for drug development but are critical in the fields of toxicology, occupational health, and environmental microbiology.

Other names

PnpAp-nitrophenol hydroxylase4-nitrophenol 4-monooxygenasep-nitrophenol monooxygenaseCYP2E1 (mammalian component)

These enzymes catalyze the oxidative hydroxylation of p-nitrophenol to 4-nitrocatechol or hydroquinone, facilitating either environmental degradation in bacteria or metabolic clearance in mammals.